[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL HEMODIALYSIS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL HEMODIALYSIS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL HEMODIALYSIS MARKET, BY CATHETERS TYPE
5.1 OVERVIEW
5.2 SHORT-TERM HEMODIALYSIS CATHETERS
5.3 LONG-TERM HEMODIALYSIS CATHETERS

6 GLOBAL HEMODIALYSIS MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 TUNNELED CATHETERS
6.2.1 CUFFED TUNNELED CATHETERS
6.2.2 NON-CUFFED TUNNELED CATHETERS
6.3 NON-TUNNELED CATHETERS

7 GLOBAL HEMODIALYSIS MARKET, BY TIP CONFIGURATION
7.1 OVERVIEW
7.2 STEP-TIP CATHETERS
7.3 SPLIT-TIP CATHETERS (OSA)
7.4 SYMMETRIC CATHETERS
7.5 OTHERS 

8 GLOBAL HEMODIALYSIS MARKET, BY MATERIAL
8.1 OVERVIEW
8.2 POLYURETHANE
8.3 SILICONE

9 GLOBAL HEMODIALYSIS MARKET, BY LUMEN
9.1 OVERVIEW
9.2 SINGLE-LUMEN
9.3 DOUBLE-LUMEN
9.4 TRIPLE-LUMEN 

10 GLOBAL HEMODIALYSIS MARKET, BY GEOGRAPHY
10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO

10.3 EUROPE

10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA

10.6 SOUTH AMERICA

10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA

11 GLOBAL HEMODIALYSIS MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES

12 COMPANY PROFILES

12.1 AST PRODUCTS, INCORPORATED
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS

12.2 BAYER AG
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS

12.3 BIOCOAT INCORPORATED
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS

12.4 COVALON TECHNOLOGIES LIMITED
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS

12.5 HARLAND MEDICAL SERVICES
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS

12.6 HYDROMER INCORPORATED
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS

12.7 KISCO LIMITED
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS

12.8. PRECISION COATING
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS

12.9 SURMODICS INCORPORATED
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS

12.10 ROYAL DSM
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS